hsa-miR-4689

Submitted by Anonymous on Wed, 10/30/2019 - 22:16

Pubmed

Gene symble	Title	PMID	Curated descirption	Category	Literature category
hsa-miR-4689	Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer	25756961	MiR-4689 may be a promising therapeutic agent in mutant KRAS CRC	biomarker	BC/OC research
hsa-miR-4689	Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer	25756961	Mutant KRAS functions as a broad regulator of the EGFR signaling cascade by inhibiting miR-4689, which negatively regulates both RAS/mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT pathways	mechanism	BC/OC research
hsa-miR-4689	Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia	26879603	Differentially expressed miRNAs including hsa-miR-4429 and hsa-miR-4689 might play critical roles in BA by regulating their target genes, and these two miRNAs may have the potential to become diagnostic biomarkers	biomarker	BC/OC research

Survival analysis